生物活性 | |||
---|---|---|---|
描述 | CYM-5520, as a selective and allosteric agonist for S1PR2, exhibits an EC50 of 480 nM. It is inactive on S1PR1, S1PR3, S1PR4, and S1PR5 receptors. CYM-5520 has the ability to co-bind with S1P at the S1PR2 receptor site. It is applicable in the study of osteoporosis[1][2]. CYM-5520, with an EC50 of 1.6 μM, fully activates the wild type S1PR2. In contrast, cells with the triple mutant S1PR2 do not show increased luciferase activity when stimulated with S1P, but CYM-5520 remains an effective agonist with an EC50 of 1.5 μM[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.90mL 0.58mL 0.29mL |
14.48mL 2.90mL 1.45mL |
28.95mL 5.79mL 2.90mL |
参考文献 |
---|